Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Zimmer

Showing results (201-210 of 242) with videos related to

Pageof 25
Sort By:
Neurology|September 6, 2007
Up-regulation of hippocampal serotonin metabolism in mild cognitive impairmentL Truchot, S N Costes, L Zimmer, et al.
Frontiers in Immunology|June 20, 2019
Retained NK Cell Phenotype and Functionality in Non-alcoholic Fatty Liver DiseaseNatalie Stiglund, Kristina Strand, Martin Cornillet, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 13, 2024
A type I interferon regulatory network for human plasmacytoid dendritic cells based on heparin, membrane-bound and soluble BDCA-2Francisco Venegas-Solis, Laura Staliunaite, Elisa Rudolph, et al.
Plos One|November 9, 2013
Lactobacilli regulate Staphylococcus aureus 161:2-induced pro-inflammatory T-cell responses in vitroYeneneh Haileselassie, Maria A Johansson, Christine L Zimmer, et al.
British Journal of Cancer|June 27, 2013
TERT promoter mutations in ocular melanoma distinguish between conjunctival and uveal tumoursK G Griewank, R Murali, B Schilling, et al.
ESMO Open|November 7, 2025
Retreatment, rechallenge, and escalation with subsequent immune checkpoint inhibitor therapies across cancers after initial failureI P da Silva, L Zimmer, J-Y Blay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 15, 2018
Paclitaxel with or without trametinib or pazopanib in advanced wild-type BRAF melanoma (PACMEL): a multicentre, open-label, randomised, controlled phase II trialV Urbonas, D Schadendorf, L Zimmer, et al.
The Journal of Molecular Diagnostics : JMD|August 30, 2011
Molecular methods and platforms for infectious diseases testing a review of FDA-approved and cleared assaysRajyasree Emmadi, Jerry B Boonyaratanakornkit, Rangaraj Selvarangan, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 2, 2021
Checkpoint immunotherapy of cutaneous squamous cell carcinoma in patients suffering from chronic lymphocytic leukaemia: divergent outcomes in two men treated with PD-1 inhibitorsP Jansen, G C Lodde, A Wetter, et al.
Journal of Molecular Medicine (Berlin, Germany)|December 5, 2020
TLR agonists enhance responsiveness of inflammatory innate immune cells in HLA-B*57-positive HIV patientsL Dold, L Zimmer, C Schwarze-Zander, et al.
Pageof 25

Showing results (201-210 of 242) with videos related to

Sort By:
Pageof 25
Neurology|September 6, 2007
Up-regulation of hippocampal serotonin metabolism in mild cognitive impairmentL Truchot, S N Costes, L Zimmer, et al.
Frontiers in Immunology|June 20, 2019
Retained NK Cell Phenotype and Functionality in Non-alcoholic Fatty Liver DiseaseNatalie Stiglund, Kristina Strand, Martin Cornillet, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 13, 2024
A type I interferon regulatory network for human plasmacytoid dendritic cells based on heparin, membrane-bound and soluble BDCA-2Francisco Venegas-Solis, Laura Staliunaite, Elisa Rudolph, et al.
Plos One|November 9, 2013
Lactobacilli regulate Staphylococcus aureus 161:2-induced pro-inflammatory T-cell responses in vitroYeneneh Haileselassie, Maria A Johansson, Christine L Zimmer, et al.
British Journal of Cancer|June 27, 2013
TERT promoter mutations in ocular melanoma distinguish between conjunctival and uveal tumoursK G Griewank, R Murali, B Schilling, et al.
ESMO Open|November 7, 2025
Retreatment, rechallenge, and escalation with subsequent immune checkpoint inhibitor therapies across cancers after initial failureI P da Silva, L Zimmer, J-Y Blay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 15, 2018
Paclitaxel with or without trametinib or pazopanib in advanced wild-type BRAF melanoma (PACMEL): a multicentre, open-label, randomised, controlled phase II trialV Urbonas, D Schadendorf, L Zimmer, et al.
The Journal of Molecular Diagnostics : JMD|August 30, 2011
Molecular methods and platforms for infectious diseases testing a review of FDA-approved and cleared assaysRajyasree Emmadi, Jerry B Boonyaratanakornkit, Rangaraj Selvarangan, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 2, 2021
Checkpoint immunotherapy of cutaneous squamous cell carcinoma in patients suffering from chronic lymphocytic leukaemia: divergent outcomes in two men treated with PD-1 inhibitorsP Jansen, G C Lodde, A Wetter, et al.
Journal of Molecular Medicine (Berlin, Germany)|December 5, 2020
TLR agonists enhance responsiveness of inflammatory innate immune cells in HLA-B*57-positive HIV patientsL Dold, L Zimmer, C Schwarze-Zander, et al.
Pageof 25